Alkermes Inc. is a pharmaceutical company based in Waltham, MA, specializing in providing treatment options for adult patients with schizophrenia. Their product ARISTADA offers a range of dosing options, including the innovative ARISTADA INITIO regimen, designed to help patients effectively manage their symptoms from the start.
In addition to their medication offerings, Alkermes Inc. provides access and support services, real patient stories, and expert insights to assist healthcare professionals in delivering effective treatment for their patients with schizophrenia.